| scholarly article | Q13442814 |
| P356 | DOI | 10.1017/S0033291720003505 |
| P698 | PubMed publication ID | 33046156 |
| P50 | author | Taro Kishi | Q57059240 |
| Nakao Iwata | Q83642043 | ||
| P2093 | author name string | Kazuo Mishima | |
| Yuki Matsuda | |||
| Kenji Sakuma | |||
| Makoto Okuya | |||
| P2860 | cites work | Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing | Q24570129 |
| Measuring inconsistency in meta-analyses | Q27860655 | ||
| Meta-analysis in clinical trials | Q27860779 | ||
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860868 | ||
| A Double-Blind, Placebo-Controlled, Prophylaxis Study of Lamotrigine in Rapid-Cycling Bipolar Disorder | Q29394100 | ||
| Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study | Q33959019 | ||
| Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (Trial 144: a randomized controlled study). | Q34230151 | ||
| A randomised, placebo-controlled 52-week trial of continued quetiapine treatment in recently depressed patients with bipolar I and bipolar II disorder | Q34260074 | ||
| Efficacy and Safety of Aripiprazole Once-Monthly in the Maintenance Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled, 52-Week Randomized Withdrawal Study | Q38381456 | ||
| Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis. | Q38584955 | ||
| Long-Acting Injectable Antipsychotics for Prevention of Relapse in Bipolar Disorder: A Systematic Review and Meta-Analyses of Randomized Controlled Trials. | Q38840490 | ||
| A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. | Q42613693 | ||
| A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group | Q42626284 | ||
| Risperidone long-acting injectable monotherapy in the maintenance treatment of bipolar I disorder | Q43130555 | ||
| Lithium carbonate and affective disorders. V: A double-blind study of prophylaxis of depression in bipolar illness | Q43641726 | ||
| A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder | Q44403599 | ||
| Prophylactic efficacy of lithium carbonate in manic-depressive illness. Report of the Veterans Administration and National Institute of Mental Health collaborative study group | Q45337994 | ||
| Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine | Q46921511 | ||
| Randomized, Double-Blind, Placebo-Controlled Trial of Asenapine Maintenance Therapy in Adults With an Acute Manic or Mixed Episode Associated With Bipolar I Disorder | Q47758943 | ||
| A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder. | Q48697520 | ||
| A randomized, placebo- and active-controlled study of paliperidone extended-release as maintenance treatment in patients with bipolar I disorder after an acute manic or mixed episode. | Q48721347 | ||
| Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. | Q52656684 | ||
| Real-world Effectiveness of Pharmacologic Treatments for the Prevention of Rehospitalization in a Finnish Nationwide Cohort of Patients With Bipolar Disorder. | Q53272906 | ||
| Prophylactic Lithium: A Double-Blind Trial in Recurrent Affective Disorders | Q53716380 | ||
| Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo-controlled comparison. | Q53884881 | ||
| Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness. | Q53965654 | ||
| A controlled evaluation of lithium prophylaxis in affective disorders | Q54329330 | ||
| Bipolar disorder | Q56039529 | ||
| Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician | Q57789414 | ||
| Lithium prophylaxis of depression in bipolar I, bipolar II, and unipolar patients | Q67487064 | ||
| P921 | main subject | bipolar disorder | Q131755 |
| P304 | page(s) | 1-9 | |
| P577 | publication date | 2020-10-13 | |
| P1433 | published in | Psychological Medicine | Q7256364 |
| P1476 | title | Recurrence rates in stable bipolar disorder patients after drug discontinuation v. drug maintenance: a systematic review and meta-analysis |
Search more.